INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,163,074 | +16.8% | 400,047 | +3.8% | 0.01% | +16.7% |
| Q2 2023 | $22,402,447 | +1.3% | 385,319 | +7.5% | 0.01% | -14.3% |
| Q1 2023 | $22,125,146 | -2.9% | 358,360 | -0.1% | 0.01% | 0.0% |
| Q4 2022 | $22,790,582 | -10.2% | 358,568 | +2.6% | 0.01% | -22.2% |
| Q3 2022 | $25,391,000 | +37.2% | 349,544 | +28.4% | 0.01% | +50.0% |
| Q2 2022 | $18,511,000 | -15.9% | 272,246 | +12.1% | 0.01% | -14.3% |
| Q1 2022 | $22,020,000 | -4.2% | 242,934 | -3.6% | 0.01% | 0.0% |
| Q4 2021 | $22,995,000 | +18.2% | 251,942 | +5.0% | 0.01% | +16.7% |
| Q3 2021 | $19,454,000 | +86.5% | 239,876 | +114.5% | 0.01% | +100.0% |
| Q2 2021 | $10,430,000 | +32.3% | 111,813 | +51.8% | 0.00% | 0.0% |
| Q1 2021 | $7,881,000 | +55.8% | 73,646 | +27.1% | 0.00% | +50.0% |
| Q4 2020 | $5,060,000 | +26.9% | 57,961 | +0.4% | 0.00% | 0.0% |
| Q3 2020 | $3,986,000 | +1392.9% | 57,738 | +947.9% | 0.00% | – |
| Q2 2020 | $267,000 | – | 5,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |